Cytek Biosciences Inc.
CTKB | NASDAQ
$5.62
+$0.34 (+6.44%)
Sep 22, 2026, 12:14 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -99.44M | -74M | -66.54M | -12.82M | -6.4M | -11.25M | -6.02M | -10.16M | -17.56M | -11.51M | -12.15M | -13.93M | -5.81M | -2.02M | 2.63M | -2.26M | -3.58M | -307K | 1.95M | 8.72M | 14.91M | 20.35M |
Depreciation & Amortization | 14.71M | 11.9M | 11.98M | 11.67M | 11.42M | 10.91M | 10.49M | 10.17M | 9.92M | 9.89M | 9.23M | 8.67M | 6.88M | 5.3M | 4.97M | 3.79M | 3.22M | 2.55M | 1.25M | 720K | 705K | 665K |
Stock-Based Compensation | 26.23M | 22.82M | 24.59M | 26.06M | 27.48M | 27.84M | 26.85M | 25.51M | 24.22M | 22.99M | 22.05M | 20.84M | 19.45M | 13.52M | 12.66M | 11.2M | 6.85M | 7.51M | 4.13M | 1.39M | 1.52M | 962K |
Other Working Capital | 5.11M | 2.55M | -366K | -724K | -8.87M | -11.96M | -17.41M | -27.62M | -16.38M | -13.98M | -5.68M | 5.21M | -3.54M | -4.75M | -6.29M | -2.84M | 6.66M | 8.2M | 11.05M | 7.62M | 7.51M | -809K |
Other Non-Cash Items | -1M | -2.9M | -3.47M | -14.99M | -1.69M | -1.55M | -439K | 11.21M | -2M | -2.63M | -3.34M | -2.21M | 313K | 7.33M | 8.43M | 8.46M | 10.8M | 5.86M | 5.95M | 5.9M | 2.27M | 1.99M |
Deferred Income Tax | 35.58M | 33.71M | 33.56M | -5.02M | -2.39M | -336K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 15.15M | 1.18M | -4.79M | -6.82M | -13.21M | -4.32M | -5.5M | -3.84M | 846K | -12.36M | -10.51M | -11.41M | -22.13M | -32.03M | -40.92M | -34.17M | -21.59M | -14.4M | -8.65M | -5.91M | -7.55M | -8.32M |
Operating Cash Flow | -8.77M | -7.3M | -4.69M | -1.92M | 15.2M | 21.3M | 25.38M | 32.89M | 15.43M | 6.38M | 5.28M | 1.96M | -1.3M | -7.89M | -12.23M | -12.98M | -4.31M | 1.22M | 4.63M | 10.82M | 11.85M | 15.65M |
Capital Expenditures | -8.21M | -5.4M | -4.08M | -3.99M | -4.14M | -3.76M | -3.53M | -4.19M | -4.78M | -4.94M | -4.83M | -9.88M | -9.59M | -9.55M | -9.83M | -4.51M | -4.71M | -4.64M | -4.36M | -3.27M | -2.44M | -1.71M |
Cash Acquisitions | n/a | n/a | n/a | -471K | -547K | -547K | -547K | -77K | -2K | -2K | -44.9M | -44.9M | -44.9M | -44.9M | n/a | -17M | -16.63M | -16.63M | -16.26M | 742K | 371K | 371K |
Purchase of Investments | -389.23M | -313.59M | -278.16M | -308.3M | -301.5M | -257.09M | -274.06M | -190.18M | -160.84M | -129.83M | -52.7M | -73.78M | -50.3M | -46.04M | -46.04M | -1.59M | -1.59M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 367.3M | 292.49M | 292.21M | 261.11M | 219.91M | 193.43M | 195M | 204M | 234M | 204M | 132M | 78M | 10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 84K | 87K | 145K | 165K | 66K | 43K | -43K | -286K | -251K | -234K | -123.65M | -123.67M | -123.65M | -123.59M | -120K | -40K | -371K | -371K | -371K | -371K | n/a | n/a |
Investing Cash Flow | -30.06M | -26.41M | 10.12M | -51.47M | -86.2M | -67.77M | -82.97M | 9.53M | 68.46M | 69.23M | -93.89M | -174.02M | -218.3M | -224M | -55.91M | -23.14M | -23.3M | -21.64M | -20.99M | -2.9M | -2.07M | -1.34M |
Debt Repayment | 7.25M | 5.86M | 837K | 5.01M | 2.93M | 1.54M | 3.62M | 838K | 835K | 836K | -565K | -475K | -337K | -196K | -50K | n/a | n/a | -2.77M | -2.77M | -2.77M | -4.08M | -1.31M |
Common Stock Repurchased | 63K | -4.45M | -15.07M | -22.1M | -34.08M | -32.24M | -21.61M | -49.36M | -45.84M | -44.15M | -44.21M | -9.47M | -1.11M | -128K | -71K | -71K | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -112K | -642K | -493K | 479K | 514K | 1.72M | 1.66M | 2.08M | 2.37M | 1.16M | 1.51M | 3.1M | 3.04M | 3.85M | 3.64M | 924K | 698K | n/a | n/a | 119.73M | 119.82M | 123.9M |
Financial Cash Flow | 7.86M | 2.09M | -13.43M | -15.85M | -29.87M | -28.98M | -15.82M | -45.94M | -42.13M | -40.2M | -41.81M | -4.21M | 4.22M | 5.15M | 5.51M | 1.68M | 218.6M | 213.74M | 213.56M | 333.27M | 114.98M | 122.78M |
Net Cash Flow | -26.81M | -29.63M | -7.89M | -69.02M | -102.45M | -73.84M | -68.89M | -1.33M | 46.37M | 36.75M | -131.87M | -177.89M | -218.35M | -230.11M | -65.12M | -35.25M | 190.05M | 193.92M | 198.5M | 341.24M | 124.52M | 136.47M |
Free Cash Flow | -16.98M | -12.7M | -8.77M | -5.9M | 11.06M | 17.53M | 21.85M | 28.7M | 10.66M | 1.44M | 454K | -7.91M | -10.9M | -17.45M | -22.06M | -17.49M | -9.02M | -3.42M | 266K | 7.55M | 9.42M | 13.94M |
Adj. Free Cash Flow | -43.21M | -35.51M | -33.36M | -31.97M | -16.41M | -10.3M | -5M | 3.19M | -13.56M | -21.55M | -21.59M | -28.76M | -30.34M | -30.97M | -34.72M | -28.69M | -15.87M | -10.93M | -3.87M | 6.16M | 7.9M | 12.98M |
Maintenance CapEx | -7.56M | -4.75M | -3.44M | -3.89M | -3.75M | -3.37M | -2.52M | -2.15M | -2.35M | -1.53M | -1.83M | -7.12M | -7.11M | -7.25M | -6.96M | -2.16M | -2.56M | -2.92M | -3.23M | -2.4M | -1.87M | -1.5M |
Growth CapEx | -648.57K | -648.57K | -648.57K | -94.23K | -393.4K | -393.4K | -1.02M | -2.04M | -2.43M | -3.41M | -3M | -2.76M | -2.48M | -2.3M | -2.87M | -2.36M | -2.16M | -1.71M | -1.14M | -869.76K | -568.99K | -203.66K |
Owner Earnings | -16.33M | -12.05M | -8.12M | -5.81M | 11.46M | 17.93M | 22.86M | 30.74M | 13.08M | 4.85M | 3.46M | -5.16M | -8.41M | -15.15M | -19.19M | -15.13M | -6.87M | -1.71M | 1.4M | 8.42M | 9.98M | 14.14M |
Add to Watchlist
Select watchlists to add or remove CTKB